The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-4-(3-hexylureido)-N-(4-(2-(2-hydroxy-3-(4-hydroxyphenoxy)propylamino)-2-methylpropyl)phenyl)benzenesulfonamide ID: ALA1077617
PubChem CID: 46882763
Max Phase: Preclinical
Molecular Formula: C32H44N4O6S
Molecular Weight: 612.79
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CC(C)(C)NC[C@H](O)COc3ccc(O)cc3)cc2)cc1
Standard InChI: InChI=1S/C32H44N4O6S/c1-4-5-6-7-20-33-31(39)35-25-12-18-30(19-13-25)43(40,41)36-26-10-8-24(9-11-26)21-32(2,3)34-22-28(38)23-42-29-16-14-27(37)15-17-29/h8-19,28,34,36-38H,4-7,20-23H2,1-3H3,(H2,33,35,39)/t28-/m0/s1
Standard InChI Key: PJORFOHALZCPRN-NDEPHWFRSA-N
Molfile:
RDKit 2D
43 45 0 0 0 0 0 0 0 0999 V2000
8.9209 -1.2220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5123 -0.5088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0990 -1.2194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8036 -0.6214 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2207 -1.3388 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.6334 -0.6189 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.3458 -2.9986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6326 -2.5857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9195 -2.9986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2063 -2.5857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4931 -2.9986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7799 -2.5857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0643 -2.9978 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.6504 -2.5840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3660 -2.9961 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.6494 -1.7583 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.0807 -2.5823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7954 -2.9965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5096 -2.5835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5091 -1.7569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7884 -1.3450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0772 -1.7605 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9394 -1.7533 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.6544 -1.3400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3686 -1.7540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0831 -1.3415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0832 -0.5148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3628 -0.1024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6513 -0.5173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7976 -0.1006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2278 -0.0980 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.9420 -0.5126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6581 -0.1014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3723 -0.5161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6601 0.7244 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.0884 -0.1049 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.8026 -0.5195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7990 -1.3440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5123 -1.7586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2295 -1.3474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2288 -0.5173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5149 -0.1065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9441 -1.7611 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20 5 1 0
6 5 2 0
5 23 1 0
12 13 1 0
23 24 1 0
7 8 1 0
24 25 2 0
13 14 1 0
25 26 1 0
26 27 2 0
14 15 1 0
27 28 1 0
8 9 1 0
28 29 2 0
29 24 1 0
14 16 2 0
27 30 1 0
30 2 1 0
2 1 1 0
2 31 1 0
15 17 1 0
31 32 1 0
9 10 1 0
32 33 1 0
17 18 2 0
33 34 1 0
3 2 1 0
33 35 1 6
18 19 1 0
34 36 1 0
10 11 1 0
36 37 1 0
19 20 2 0
37 38 2 0
5 4 2 0
38 39 1 0
20 21 1 0
39 40 2 0
11 12 1 0
40 41 1 0
21 22 2 0
41 42 2 0
42 37 1 0
22 17 1 0
40 43 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 612.79Molecular Weight (Monoisotopic): 612.2982AlogP: 5.25#Rotatable Bonds: 17Polar Surface Area: 149.02Molecular Species: BASEHBA: 7HBD: 6#RO5 Violations: 3HBA (Lipinski): 10HBD (Lipinski): 6#RO5 Violations (Lipinski): 3CX Acidic pKa: 8.03CX Basic pKa: 9.38CX LogP: 4.02CX LogD: 3.39Aromatic Rings: 3Heavy Atoms: 43QED Weighted: 0.11Np Likeness Score: -0.95
References 1. Pasternak A, Goble SD, deJesus RK, Hreniuk DL, Chung CC, Tota MR, Mazur P, Feighner SD, Howard AD, Mills SG, Yang L.. (2009) Discovery and optimization of novel 4-[(aminocarbonyl)amino]-N-[4-(2-aminoethyl)phenyl]benzenesulfonamide ghrelin receptor antagonists., 19 (21): [PMID:19767208 ] [10.1016/j.bmcl.2009.08.076 ]